NOW: Clinical & Urgent Care
Every day, 1.2 million Americans visit an urgent care clinic or emergency room with respiratory symptoms. Clinicians need to know — flu, RSV, COVID, or something else — before the patient leaves the room.
Today that means either waiting hours for a lab result or accepting the limitations of rapid tests that miss too much.
Varro changes that calculus.
The Varro swab device delivers PCR-level accuracy in under 60 seconds. No lab. No send-out. A clinician gets a definitive answer while the patient is still in the exam room.
Why it matters
- Reimbursable per test at standard diagnostic rates
- High-volume from every placed device
- Designed for the FDA 510(k) pathway — clearance targeted 2027
- Built on peer-reviewed validation: 95.5% sensitivity, published in ACS Sensors, NIH RADx-RAD funded
NEXT: Institutional & Government
Where the platform scales. Where the contracts compound. Where Varro becomes infrastructure.
A hospital knows when a patient tests positive. It has no idea what’s circulating in its own corridors, waiting rooms, or ventilation zones until it already has an outbreak.
An airport processes 100,000 passengers a day. It has no biological sensing capability whatsoever.
A government agency responsible for national biosurveillance is still relying on voluntary reporting and lagged PCR data to make real-time decisions.
The gap isn’t just a technology problem — it’s also a deployment problem. Varro solves both.
The Varro Breath device and AirBioDetector bring continuous, non-invasive biological monitoring to any institutional environment — no clinician required, no disruption to operations. Each deployed node feeds live data back to Varro’s intelligence network, compounding in value with every additional installation.
Why it matters
- Contracts replace per-test reimbursement with predictable recurring revenue
- High demand for real-time data from BARDA, DHS, and municipal health agencies
- Breath device enables mass screening without physical contact or consent barriers
- AirBioDetector provides 24/7 ambient monitoring — airports, transit hubs, federal buildings, hospitals
Target environments
Hospitals & health systems · Airport terminals · Transit infrastructure · Corporate campuses · Government facilities · National security environments
This is where Varro’s network effect begins. Clinical deployment proved the platform works. Institutional deployment proves it scales. Every node added to the network increases the value of every node already in it — and makes the intelligence layer that sits on top of all of it more powerful, more defensible, and harder for any competitor to replicate.
FUTURE: Ambient Infrastructure
The long game and the compounding asset for Varro. The built environment has sensors for everything. Temperature. Humidity. CO₂. Motion. Fire. Flood. Biology is the only signal it has never been able to monitor — until now.
Imagine a hospital that knows a respiratory pathogen is circulating in its east wing twelve hours before the first patient presents with symptoms. An airport that detects an emerging outbreak in Terminal C before a single passenger boards a connecting flight. A military installation that receives an alert before a detected pathogen becomes a national security threat.
This is not surveillance. This is infrastructure — as fundamental to a building’s operating system as the fire suppression system or the HVAC network.
Varro’s AirBioDetector makes biological sensing a permanent, ambient layer of every built environment it enters.
Why it matters
- Subscription-based deployment — hardware placed, software licensed, data aggregated
- Each node feeds the intelligence network, compounding signal value across every connected environment
- Agriculture applications extend the platform to supply chain biosecurity — crop pathogen detection, livestock monitoring, food safety
- National security environments represent an important deployment tier
- Funded in part by NIH RADx-RAD, BARDA, and DOD — validation that the hardest buyers already believe
Target environments:
- Hospitals & health systems
- Commercial real estate
- Schools & universities
- Transit hubs & airports
- Agricultural operations
- Military installations
- National security facilities
This is where the network creates the greatest value. Clinically validated accuracy. Institutional proved scale. A Varro node installed in a building in 2028 is still generating data and still getting smarter in 2035. The longer the network runs, the more valuable its data becomes.